Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAVITAS: Liraglutide for poor responders after bariatric surgery
2014-003923-23Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Imperial College London. Primary endpoint: HbA1c reduction from baseline. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on 2014-003923-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003923-23.